Although MUC-2 has been shown to have protective capacities, we found that it was upregulated during cisplatin-induced mucositis, especially on day 3, and it reverted to a normal level by day 6 in the probiotic+cisplatin group. The gene discussed is MUC2; the disease is mucositis.